The advent of human embryonic stem (ES) cells and induced pluripotent stem (iPS) cells had a paradigm-shifting effect on regenerative medicine
a powerful new treatment against diseases underlined by cell loss, tissue degeneration and aging.
With these applications came critical and important challenges:
uncontrolled proliferation and genetic mutations
in therapeutic cells that pose safety risks to patients.
panCELLa has developed a solution to these challenges.
Quantifying & Mitigating the Risk
Engineering cells to give us total control over their fate:
The solution to safe cell therapies
The FailSafe System
FailSafe cells use cell division loci to control cell proliferation (Continue Reading)
panCELLa technology allows one to provide a precise definition of safety and to quantify the safety level of a prospective cell therapy. The integration of the FailSafe cell system in cell therapies will be critical for regulators, clinicians and patients to make informed decisions. To make your cell therapy a FailSafe cell therapy, contact panCELLa today